Releases Geral
Oracle Corporation has released the following notice
AGÊNCIA DE COMUNICAÇÃO Conteúdo de responsabilidade da empresa 22 de agosto de 2024
Oracle Corporation
AUSTIN, Texas, Aug. 22, 2024 (GLOBE NEWSWIRE) —
UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA SAN JOSE DIVISION |
||
In re ORACLE CORPORATION STOCKHOLDER DERIVATIVE LITIGATION This Document Relates to: ALL ACTIONS |
Lead Case No. 5:19-cv-00764-BLF
SUMMARY NOTICE OF PENDENCY AND SETTLEMENT OF DERIVATIVE ACTION Related Derivative Case: 5:19-cv-02448-BLF |
|
Judge: Hon. Beth Labson Freeman Date First Action Filed: Feb. 12, 2019 |
TO: | ALL PERSONS AND ENTITIES THAT HELD ORACLE CORPORATION (ORACLE) COMMON STOCK AS OF MARCH 22, 2024 AND WHO CONTINUE TO HOLD SHARES THROUGH THE DATE OF THE FINAL FAIRNESS HEARING (CURRENT ORACLE STOCKHOLDERS). |
PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY.
IF YOU ARE A CURRENT ORACLE STOCKHOLDER, YOUR RIGHTS WILL BE AFFECTED BY THIS SETTLEMENT.
YOU ARE HEREBY NOTIFIED of a proposed settlement (Settlement) of the above-referenced shareholder derivative action (the Action). If the Court approves the proposed Settlement, all Current Oracle Stockholders (defined below) will forever be barred from contesting the fairness, adequacy, and reasonableness of the Settlement and from pursuing the Released Plaintiffs Claims. All capitalized terms used in this notice that are not defined have the meanings provided in the Stipulation of Settlement entered into on March 22, 2024 (Stipulation), by (1) Lead Plaintiff City of Providence (Lead Plaintiff); (2) Lawrence J. Ellison, Safra A. Catz, and Paula R. Hurd, as Trustee of the Hurd Family Trust and personal representative of the Estate of Mark Hurd1 (the Individual Defendants); and (3) nominal defendant Oracle (together with the Individual Defendants, Defendants). THIS NOTICE PROVIDES ONLY A SUMMARY OF THE SETTLEMENT. You can obtain more information by reviewing the Stipulation, as well as the full Notice of Pendency and Settlement of Stockholder Derivative Action (Notice), both of which are available on Oracles investor relations website at https://investor.oracle.com, and on Lead Plaintiffs Counsels website at www.labaton.com.
In exchange for the Settlement and the releases provided for, subject to the terms of the Stipulation, the Parties have agreed to several corporate governance measures for a period of at least five years from the Effective Date of the Settlement that implement review procedures after Oracles quarterly earnings conference calls and consideration of whether any correction, amendment, or change to any of the statements made during the call should be considered.
Co-Lead Counsel have not received any attorneys fees for their work, and will ask the Court, on behalf of Plaintiffs Counsel, for an award of attorneys fees, payment of reasonable litigation expenses, and a service award for Lead Plaintiff (Fee and Expense Amount). The total request by Plaintiffs Counsel will not exceed $700,000. Oracle will pay the Fee and Expense Amount awarded by the Court. Oracle Stockholders are not personally liable for any such fees or expenses.
PLEASE ALSO TAKE NOTICE that a Settlement Fairness Hearing will be held before United States District Judge Beth Labson Freeman on November 14, 2024, at 8:45 am., either in person at the United States District Court for the Northern District of California, San Jose Courthouse, Courtroom 3 5th Floor, 280 South 1st Street, San Jose, CA 95113, or by telephone or video conference (in the discretion of the Court), to consider whether the Judgment, substantially in the form of Exhibit A to the Stipulation, should be entered: (i) approving the terms of the Settlement as fair, reasonable, and adequate and in the best interests of Oracle and Oracles stockholders; (ii) dismissing the Action with prejudice, pursuant to the terms of the Stipulation; and (iii) ruling upon applications for the Fee and Expense Amount.
Please Note: The date and time of the Settlement Fairness Hearing may change without further written notice to Current Oracle Stockholders. Any changes and procedures related to remote participation will be posted on Oracles investor relations website at https://investor.oracle.com and Lead Plaintiffs Counsels website at www.labaton.com.
Any person or entity who or which owned Oracle common stock as of March 22, 2024 and continues to hold the stock as of the date of the Settlement Fairness Hearing (Current Oracle Stockholder) may object to the approval of the proposed Settlement and/or any application for the Fee and Expense Amount, and appear at the hearing to explain their views, provided that they file any such objections with the Court no later than October 24, 2024, according to the instructions in the full Notice. The Court can only approve or deny the proposed Settlement; it cannot change the terms of the Settlement.
Because the Settlement resolves a derivative lawsuit, which was brought on behalf of and for the benefit of Oracle rather than individual class members, the benefits from the Settlement will go to Oracle. Current Oracle Stockholders will not receive any direct payment from the Settlement and Current Oracle Stockholders cannot request exclusion.
ACCORDINGLY, THERE IS NO PROOF OF CLAIM FORM FOR STOCKHOLDERS TO SUBMIT IN CONNECTION WITH THIS SETTLEMENT.
If you have any questions regarding this notice, the Action, or the Settlement, you may contact Co-Lead Counsel:
Mark C. Molumphy, Esq.
Cotchett, Pitre & McCarthy
840 Malcolm Road, Suite 200
Burlingame, California 94010
(650) 697-6000
mmolumphy@cpmlegal.com
Alfred L. Fatale III, Esq.
Labaton Keller Sucharow LLP
140 Broadway
New York, NY 10005
(888) 219-6877
settlementquestions@labaton.com
PLEASE DO NOT CONTACT THE COURT, DEFENDANTS, OR DEFENDANTS COUNSEL REGARDING THIS NOTICE
DATED: August 8, 2024 | BY ORDER OF THE U.S. DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA |
____________________________
1 Defendant Mark Hurd passed away during the pendency of the Action.
A OESP nao e(sao) responsavel(is) por erros, incorrecoes, atrasos ou quaisquer decisoes tomadas por seus clientes com base nos Conteudos ora disponibilizados, bem como tais Conteudos nao representam a opiniao da OESP e sao de inteira responsabilidade da GlobeNewswire
Leia também
-
Releases Geral Boehringer expands production site in Greece for new medicine
11 de janeiro de 2024Boehringer Ingelheim Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of
Saiba Mais -
Releases Geral nCino Signs Definitive Agreement to Acquire FullCircl
30 de outubro de 2024WILMINGTON, N.C. and LONDON, Oct. 30, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today ann
Saiba Mais -
Releases Geral Vika Ferrari conduz encontro entre empresárias
19 de junho de 2024Florianópolis, SC--(DINO - 13 jun, 2024) - A cidade de Florianópolis receberá no dia 16 de junho a 1ª edição do Flawless Day, um encontro ded
Saiba Mais